Pharmaceutical & Nutraceutical - Specialty Supplements & Medical Devices
Strategic Profile
Pharmanutra produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries, offering iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products as well as medical instrumentation and software for body bioimpedance analysis. The company focuses on studying and producing formulations that are backed up in scientific research.
Cyborg Score Rationale
The company has a market capitalization of $739M with trailing twelve month revenue of $141M. Strong market position in nutraceuticals with diversified product portfolio and international presence. Moderate valuation at 25.37x PE with favorable dividend yield supports investor confidence.
Top Insights
Diversified product ecosystem spanning iron supplements (SiderAL), anti-inflammatory (Cetilar), and specialty medical devices with strong scientific backing
Established in 2003 with 23-year operational track record demonstrating sustainable business model in highly regulated healthcare sector
International distribution across six continents through multi-channel strategy (pharmacies, wholesalers, online, tenders) reducing geographic concentration risk
Market cap of €739M indicates mid-cap positioning attractive for growth-focused investors in European healthcare space
Named Competitors
Specialized supplements — European pharmaceutical company competing in specialty drugs
General nutraceuticals — Large multinational with diversified supplement portfolio
Recent Developments
(Sep 2025) Earnings call conducted; stock trading near 44.40 EUR with 1-year target at 81.00 EUR indicating analyst upside potential
(Feb 2026) Current market cap standing at €739M with stock price at €77.01 representing significant year-to-date appreciation
Open the full interactive Pharmanutra S.p.A. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.